The letter submitted by the FAH in response to the Federal Trade Commission’s March 2014 Examining Health Care Competition workshop centers on price and quality transparency. It also includes our recommendations on a third, critically important issue: the corporate practice of medicine. The FAH believes the FTC should reexamine the anti-competitive effects of the corporate practice of medicine doctrine. Defined as “the practice of corporations hiring physicians for purposes of generating profits”, state corporate practice of medicine restrictions have been in place since the turn of the 20th century. While these restrictions are intended to protect the public from corporate […] Read More